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Background: Lung transplantation (LT) is a recognized treatment for end-stage
pulmonary disease. Bacteria from the recipient nasopharynx seed the new lungs leading
to infections and allograft damage. Understanding the characteristics and topological
variations of the microbiota may be important to apprehend the pathophysiology of
allograft dysfunction.
Objectives: To examine the characteristics and relationship of bacterial compositions
between conducting and respiratory zones of the allograft.
Methods: We performed 16S rRNA gene sequencing on bronchial aspirates (BAs) and
bronchoalveolar lavages (BALs) collected in pairs in 19 patients at several time-points
post-LT.
Results: The respiratory zone was characterized independently of the time post-LT by a
higher bacterial richness than the conducting zone (p= 0.041). The phyla Firmicutes and
Proteobacteria dominated both sampling zones, with an inverse correlation between
these two phyla (Spearman r = –0.830). Samples of the same pair, as well as pairs
from the same individual clustered together (Pseudo-F = 3.8652, p < 0.01). Microbiota
of BA and BAL were more closely related in samples from the same patient than
each sample type across different patients, with variation in community structure being
mainly inter-individual (p < 0.01). Both number of antibiotics administered (p < 0.01)
and time interval post-LT (p < 0.01) contributed to the variation in global microbiota
structure. Longitudinal analysis of BA–BAL pairs of two patients showed dynamic wave
like fluctuations of the microbiota.
Conclusions: Our results show that post-transplant respiratory zones harbor higher
bacterial richness, but overall similar bacterial profiles as compared to conductive zones.
They further support an individual microbial signature following LT.
Keywords: microbiota, lung transplantation, conducting airways, respiratory airways, lung allograft
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INTRODUCTION
Lung transplantation (LT) is the sole therapeutic intervention
for patients with end-stage pulmonary disease. With 3893
lungs transplanted in 2013 in 242 European and US lung
transplant centers, this procedure is an increasing common
approach according to the International Society for Heart and
LT Registry (Yusen et al., 2015). However, the outcome after
LT is worse compared to other solid organ transplantations,
with a median survival of 5.7 years post-LT (Yusen et al.,
2015). Mortality during the 1st year post-LT is mainly due to
infections, whereas late mortality is linked to chronic rejection,
notably the bronchiolitis obliterans syndrome (BOS). Cystic
fibrosis (CF) lung-transplant recipients are at particularly high
risk of infection due to chronic pre-transplant colonization with
microorganisms including Staphylococcus aureus, Haemophilus
influenzae, and Pseudomonas aeruginosa, the latter being the
most frequent pathogen in adult CF-patients (Cystic Fibrosis
Foundation, 2011). Preventing infections is one of the major
challenges to increase allograft survival and to improve outcome
after LT.
Airways are composed of several interconnected
compartments, i.e., the sinuses, the trachea, the conducting,
and the respiratory zones (Figure 1A). After removal of
the major site of infections (i.e., the lungs) by LT, bacteria
that remain in the sinuses seed the allograft. Polymicrobial
communities of LT-recipients appear to be distinct from those
of healthy subjects (Charlson et al., 2012; Borewicz et al., 2013).
Relationships between upper and lower airways microbiota are
not fully understood. Our previous study demonstrated that
colonization of the new lungs by P. aeruginosa occurs within
the 1st days after LT in CF patients (Beaume et al., 2015).
Other studies have shown differences between sputum and
lower airway microbiota in patients with lung disease such
as CF and chronic obstructive pulmonary disease (COPD)
(Cabrera-Rubio et al., 2012; Goddard et al., 2012). Despite an
increasing number of studies related to the microbiota of LT-
recipients, no comparison between the intermediate (conducting
zone) and lower (respiratory zone) airway environments has
been performed. It is still unknown if transplanted-lungs have
a uniform microbiota, or if specific microbial populations
colonize different regions of the allograft. While the presence
of the mucociliary movements can favor the homogeneity of
the microbiota in the airways, recurrent bacterial seeding of
the graft from the naso and oro-pharyngeal reservoir may
establish a gradient from the upper to the lower airways.
Understanding the regional disparities of the airway microbiota
may therefore contribute to characterize the complex graft
environment and to apprehend the pathophysiology of graft
infections.
The objective of this study was to characterize and
compare the microbiota from bronchial aspirates (BAs) and
bronchoalveolar lavages (BALs) samples collected simultaneously
from CF and non-CF lung-transplant recipients. We thus
assessed the microbiota of the conducting and respiratory
zones and, the impact of time post-transplantation, CF, use of
antibiotics and patient age on microbiota profiles. We further
analyzed changes of the allograft microbiota in sequential airway
samples from two non-CF patients.
MATERIALS AND METHODS
Subject Recruitment and Sample
Collection
This prospective observational work was part of the Swiss
Transplant Cohort Study (STCS) (Koller et al., 2013).
Authorization to use all clinical samples for research purposes
was obtained from the local ethical committee and all patients
provided their written consent. Pulmonary function, including
the forced expiratory volume (FEV1), was followed by routine
spirometry at regular time intervals after LT. The clinical
diagnosis of BOS was defined by a sustained pulmonary decline,
with a FEV1 reduction of >20% compared to baseline, after
excluding confounding factors (Verleden et al., 2014). The two
best FEV1 values at a > 3 week time interval obtained during the
first 6 months after LT were used to define the baseline, for the
purpose of this study.
Pairs of BAs and BALs were collected during routine
surveillance bronchoscopies. BAs consisted of respiratory
secretions aspirated below the bronchial suture, and representing
heterogeneous samples from both lungs at the level of the
conducting zone. After rinsing the working channel of the
bronchoscope with 5 mL saline, the bronchoscope was wedged
in 3–5th generation airways and washed again by the instillation
of 150 ml of NaCl 0.9% into the distal airways. BAL fluid was
obtained by aspiration of 10–20 ml distal respiratory secretions,
thus representing a more homogenous sample from a distal
respiratory zone. 1 mL of each airway sample was immediately
stored at−80◦C after sampling.
Evaluation of Potential
Cross-Contamination between BA and
BAL
Ten milliliters of a solution containing 8.5 × 103 cells/mL
of P. aeruginosa strain PAO1 were aspirated ex vivo with the
bronchoscope. This first aspirate was called “pseudo-BA.” After
rinsing the working channel of the bronchoscope with 5 mL NaCl
0.9%, 150 mL of NaCl were instilled through the bronchoscope
in a solution containing 1.9 × 105 cells of S. aureus strain
Newman. 10 ml of this mixture was then aspirated using the
same bronchoscope in a sterile container. This second aspirate
was called “pseudo-BAL.” Hundred microliter of the pseudo-
BA and pseudo-BAL were plated in duplicate on Cetrimide
Agar and LB supplemented with 10 µg/mL of Aztreonam.
Plates were incubated 24 h at 37◦C. Bacterial DNA was also
extracted from 1 mL of the pseudo-BA and pseudo-BAL, and
submitted to analysis by qPCR as described in the Supplementary
Material.
gDNA Extraction
For 16S analysis, genomic DNA was isolated from BA and
BAL using the DNeasy kit (QIAGEN) according to the
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FIGURE 1 | Collection of bronchial aspirate–bronchoalveolar lavage (BA–BAL) pairs from lung-transplant recipients. (A) Both zones were explored
during the same procedure, with the conducting zone being sampled by performing a BA and the respiratory zone by BAL. (B) Dots represent BA–BAL pairs
collected for each of the 19 patients after lung-transplantation. Gray dots refer to CF patients, whereas black dots depict non-CF patients.
manufacturer’s instructions. Additional details are provided in
the Supplementary Material.
16S rRNA Gene Amplification,
Sequencing, and Taxonomic Analysis
The hypervariable regions V4–V6 of the 16S rRNA
gene were amplified by PCR using primers Uni16_518F
(CCAGCAGCYGCGGTAAN) and Uni16_1064R (CGACRRCC
ATGCANCACCT) (Filkins et al., 2012). Additional details are
provided in the Supplementary Material.
PCR products were sequenced by using an Illumina MiSeq
platform (Fasteris SA, Plan-les-Ouates, Switzerland). We used a
paired-end protocol allowing to sequence 300 bases of the 5′-
end and 300 bases of the 3′-end of each fragment. Sequence
files were deposited in EMBL-ENA under the accession number
PRJEB13210. A custom bioinformatic pipeline performed quality
filtering to remove low quality reads. The reads obtained were
first mapped on the 18S human rRNA gene by using the
BWA software (v0.5.9) to deplete contaminant reads. BWA-
MEM (Version: 0.7.5a-r405) was then used to map remaining
reads onto the Greengenes database (file gg_97_otus_4feb2011)
(DeSantis et al., 2006) with 97% identity to assign them to specific
taxon. Counts were then normalized as relative frequencies per
sample and per taxon.
Statistical Analysis
Alpha-diversity (non-parametric Shannon index) and richness
(S observed) were calculated by using the VEGAN package1.
1http://vegan.r-forge.r-project.org/
Calculation was performed for each sample on 7,000 reads taken
randomly from the pool of reads. Variations in the alpha-diversity
among samples were tested with a linear regression model with
mixed effects because measures were repeated overtime.
To compare bacterial communities, we constructed a Bray–
Curtis (Bray and Curtis, 1957) similarity matrix based on
the square-root-transformed relative abundance of operational
taxonomic units (OTUs). Principal coordinates analysis (PCoA)
of Bray–Curtis similarities was performed in PRIMER (Primer-
E Ltd., Plymouth, UK). To assess differences between BAs
and BALs or CF and non-CF samples, we used one-way
permutational multivariate analysis of variance (PERMANOVA)
of the Bray–Curtis similarity matrix. Distance-based linear model
(DISTLM) was used for analyzing the relationship between
bacterial community structures and quantitative continuous
variables (age, number of antibiotics used, and day post-LT).
Similarity percentage (SIMPER) was used to identify OTUs which
contribute to the distinction between BA and BAL samples. In
addition, Wilcoxon signed rank test was used to assess statistical
significance of differences in taxa abundance between BAs and
BALs. P-values were adjusted using the false discovery rate (FDR)
method for multiple comparisons.
RESULTS
Sample and Patient Characteristics
Thirty-eight paired BA and BAL samples were obtained from
19 lung-transplant recipients at different time-points post-LT
(Table 1; Figure 1B). Fifty percent of the BA–BAL pairs were
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TABLE 1 | Patient characteristics.
Patient n◦ Pre-transplant
disease∗
Gender Age at LT
(years)
Extubation
(day post-LT)
CFTR
genotype
Transplant
type∗∗
P. aeruginosa
colonization before LT
1 COPD F 63 1 R No
2 COPD F 61 41 Bi No
3 COPD M 63 0 Bi No
4 COPD F 60 2 Bi No
5 ILD M 52 34 Bi Yes
6 ILD F 44 24 Bi No
7 COPD F 55 1 Bi Yes
8 COPD F 54 2 Bi No
9 Br F 47 50 Bi Yes
10 Br F 61 39 Bi Yes
11 COPD F 54 1 Bi No
12 COPD F 58 1 Bi No
13 ILD F 50 41 Bi No
14 CF F 32 4 dF508 Bi Yes
15 CF M 39 10 nd Bi Yes
16 CF M 15 3 dF508 Bi Yes
17 CF M 27 115∗∗∗ dF508 (Bi), R Yes
18 CF M 23 1 dF508 Bi Yes
19 CF M 20 0 dF508 Bi Yes
∗CF, cystic fibrosis; COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease; Br, Bronchiectasis. ∗∗Bi, bilateral; R, unilateral right. Note that patient #17
was subjected to a bilateral LT 1 year before this study followed by a unilateral right LT, which is the transplantation considered in this study. ∗∗∗Removal of tracheostomy
tube. nd, not determined.
collected during the first 100 days. Thirteen patients were
transplanted for COPD, interstitial lung disease or bronchiectasis,
whereas six patients were transplanted for end-stage CF-
disease. Most patients (89%) underwent bilateral transplantation.
Bronchoscopies were performed as part of routine surveillance
procedures at regular time intervals during the first 3 years
post-LT. Patients #4, #18, and #19 developed a BOS at 91, 794,
and 325 days post-LT, respectively. Patients #4 and #19 died
during our study at 365 and 424 days post-LT, respectively,
from irreversible allograft dysfunction. All patients were on
immunosuppressive and antimicrobial treatments according to
local practice for LT-recipient management.
Evaluation of Potential
Cross-Contamination between BA and
BAL
To evaluate if a cross-contamination could occur between BA
and BAL samples, we performed an ex vivo control experiment
closely mimicking the bronchoscopy procedure. Using the
same bronchoscope, we successively aspirated a pure culture
of P. aeruginosa (pseudo-BA), rinsed the bronchoscope and
aspirated a pure culture of S. aureus (pseudo-BAL). Whereas
the “pseudo-BA” yielded an average of 1.9 × 102 CFU/mL
(SD = 99.0) P. aeruginosa and no S. aureus, the “pseudo-BAL”
yielded 1.2 × 102 CFU/mL (SD = 40.3) of S. aureus but no
P. aeruginosa. The absence of detectable cross-contamination was
further confirmed by qPCR as Ct values obtained in the “pseudo-
BAL” for P. aeruginosa were similar to those obtained with the no
template controls.
Sequence Data Set
After DNA extraction from native samples (BAs and BALs),
the V4–V6 segment of the bacterial 16S rRNA gene was
amplified and sequenced using Illumina sequencing technology.
A median of 64765 (range 1378–746584) and 57228 (range 3747–
1235360) sequences were obtained for the BA and BAL samples,
respectively (Supplementary Table S1). Due to low sequencing
coverage, the two BA–BAL pairs from patient #18 were not
included in the analyses. After normalization to 7000 reads per
sample, 36 pairs of BA–BAL samples deriving from 18 patients
remained analysable.
Bacterial Richness and Diversity in
Post-LT Airway Samples
We characterized the BA–BAL pairs by calculating the observed
OTU richness (S) and the Shannon diversity index. An important
variability of both indices was observed between all samples.
When all 36 pairs of samples were included, our analysis revealed
that the observed richness in BAL samples was in average 44.1
units higher than in BA samples (95% CI 1.8–86.4) (Figure 2A).
The mean difference was significantly different from 0 (p-
value = 0.041, linear mixed model). Difference in 95% of the
measures ranged between −80 and 269, indicating an important
variability. The S value decreased by 22% for each year post-
LT (Figure 2C, Supplementary Table S2). However, statistical
analysis on S values demonstrated that the effect of time was not
significant neither for BA nor for BALs samples (p = 0.08, linear
regression with mixed effects). No time effect was also reported
during the 1st year post-LT (p= 0.70). In addition, the interaction
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FIGURE 2 | Alpha-diversity of the conducting and respiratory microbiota of lung-transplanted patients. Richness was calculated with the S observed
estimator, and alpha-diversity was estimated with the Shannon index. Dots represent non-CF patients, whereas squares represent CF-patients. Y-axis corresponds
to the differences of values obtained for BAL minus the one calculated for BA. The horizontal line represents the mean difference in S or Shannon (BAL−BA). (A,B)
Bland–Altman plots representing the average of the values obtained for BAL and BA for each pair in X-axis. (C,D) Differences of S and Shannon over time post-LT.
term between the time post-LT and the type of sample was not
statistically significant (p= 0.27).
In addition, we observed that the mean difference in Shannon
of BAL minus BA was 0.54 (95%CI −0.01–1.09) (Figure 2B).
However, the mean difference was not significantly different
from 0 (p-value = 0.055, linear mixed model). Differences in
Shannon values also showed an important variability, with a
difference in 95% of the measures comprised between −0.89 and
2.76. The Shannon index showed a decrease of 0.29 units of
Shannon for each year post-LT (Figure 2D, Supplementary Table
S2). However, statistical analysis on Shannon values indicated
no significant effect of time neither for BA samples nor BALs
(p = 0.21, linear regression with mixed effects). No effect of time
was also reported during the 1st year post-LT (p = 0.46). The
interaction term between the time post-LT and the type of sample
was not statistically significant (p= 0.27).
To remove repeated measurements, we analysed only the
first BA–BAL pair collected from each of 18 patients. A higher
OTU richness was observed in BALs relative to matched BAs
(median 438, IQR 198–764 vs. median 396, IQR 264–585, p = 1
by Wilcoxon signed-rank test) (Figure 3). Likewise, Shannon
diversity index was higher in BAL than in BA samples (median
3.09 IQR 2.08–3.40 vs. 2.51 IQR 1.16–2.86, p = 0.11, Wilcoxon
signed-rank test). However, these differences did not reach the
statistical significance.
Distance-based linear model test showed that the variation
on Shannon diversity was best explained by the number of
antibiotics used (15.6% of the variation, Pseudo-F = 6.2771,
p = 0.018), whereas the time interval after transplantation (3.7%
of the variation, Pseudo-F = 1.293, p = 0.245) and age (4.9% of
the variation, Pseudo-F = 1.7583, p= 0.215) had no effect.
Bacterial Community Profiles of the
Conducting and Respiratory Zones of
the Lung Allograft
We mapped the 16S rDNA reads onto the Greengenes
database with a 97% identity level and examined bacterial
communities at different taxonomic levels. BA and BAL
samples were dominated by phyla Firmicutes and Proteobacteria,
followed by Bacteroidetes and Actinobacteria (Figure 4).
These four phyla, identified in all samples, were the only
phyla with a median relative abundance >1% in any of
the two sample types. We found an inverse correlation
between Proteobacteria and Firmicutes (Spearman r = –0.830,
Supplementary Figure S1). Reads assigned to the phylum
Tenericutes were identified in nearly all (35/36) samples but
with a low relative abundance (median 0.12 and 0.16% for
BA and BAL samples, respectively). Genera Staphylococcus,
Pseudomonas, Streptococcus, and Prevotella were most abundant
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FIGURE 3 | Alpha-diversity of BA–BAL pairs collected the 1st month post-LT. S observed richness estimator (A) and Shannon index (B) calculated for the first
BA and BAL pairs collected in 18 patients. The patient’s number is indicated with the day of sampling expressed in day post-LT.
FIGURE 4 | Relative abundance of bacterial phyla across 18 pairs of BA–BAL samples. The proportion of 16S sequences assigned to phyla with a relative
abundance >1% in at least one sample is presented. Samples are presented by pairs: left, BA; right: BAL.
across samples (Supplementary Figure S2). The proportion of
several bacterial taxa differed between BA and BAL samples
(Supplementary Table S3) but most of them had low relative
abundance. For instance, at the genus and OTU levels,
significant changes were observed only for the taxa with a
proportion <0.22% of the total bacterial population, except
for the two OTUs assigned to Staphylococcus (0.41 and 0.52%,
respectively).
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FIGURE 5 | Similarities between BA and BAL microbiota. (A) Principal coordinates analysis of 38 BA and BAL pairs. The analysis was done in PRIMER, based
on square-root-transformed abundance of operational taxonomic units (OTUs) and Bray–Curtis similarity matrix. (B) Group average clustering from Bray–Curtis
similarities on root-transformed relative abundances. BAs are represented by a blue triangle whereas BALs are indicated by an inverse red triangle. Each sample is
characterized by the patient’s number followed by the day of sampling post-LT in brackets.
Microbiota Clustering
We investigated the relationship between respiratory bacterial
communities in BAs and BALs. Principal Coordinate analysis and
Hierarchical Cluster analysis of all samples showed that BA and
BAL of the same pair (same patient and day) clustered together
(Figure 5). Also, samples from the same individual obtained
at different time points tended to form clusters although some
of them clustered apart. In the first two principal coordinates,
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FIGURE 6 | PCoA of 18 pairs of BA–BAL samples. Only the first BA–BAL
pair from each individual is presented (sampling range: days 4–405, median
24.5 days). The analysis was based on Bray–Curtis similarity matrix obtained
on square-root transformed relative abundance of OTUs. (A) Symbols indicate
the type of sample (BA, BAL) and CF pathology (CF, non-CF). (B) This bubble
plot depicts the relationship between bacterial community profiles and the
number of antibiotics used, day post-LT and Shannon diversity index. The
larger the part of the pie is, the higher is the value (antibiotic: 0–5; day post-LT:
4–405; Shannon: 0.24–4.03).
most BAL samples were displaced rightward (30/36), downward
(33/36), or both (27/36) relative to the paired BA samples.
This distribution suggests a small effect of the sample type on
microbiota clustering.
The analysis which excluded repeated measurements of the
same individual and included only the first BA–BAL pair
FIGURE 7 | Intra-individual and inter-individual microbiota similarity.
Only the first BA–BAL pair from each (18) individual is presented. Bray–Curtis
similarity was based on square-root transformed relative abundance of OTUs.
Intra BA–BAL designate the similarity between BA and BAL samples taken
from the same individual at the same sampling point. Inter–BA and Inter–BAL
correspond to inter-individual similarity of BA and BAL samples, respectively.
from each of 18 patients (Figure 6, Supplementary Table S4),
confirmed strong clustering by individual (Permanova global
test, Pseudo-F = 3.8652, p = 0.0001). No effect of the type of
sample on microbiota profiles was found (Permanova Pseudo-
F = 1.4323, p = 0.1098). The similarity between BAs and
BALs microbiota collected at the same sampling point of the
same individual was significantly greater than inter-individual
similarity observed for each sample type (Figure 7). Samples
collected from CF patients did not cluster together (Figure 6A),
suggesting that there was no typical microbiota related to
CF-transplanted patients (Permanova Pseudo-F = 1.2564,
p = 0.1836). The relationship between microbiota clustering in
PCoA and the Shannon diversity, number of antibiotics used, and
time post-transplantation are given in Figure 6B.
Distance-based linear model test showed that the variation in
microbiota structure was explained by the number of antibiotics
used (7.3% of the variation, Pseudo-F = 2.685, p = 0.0007), and
by the time interval after transplantation (6.1% of the variation,
Pseudo-F = 2.1961, p = 0.0095), whereas age had no significant
effect (3.9% of the variation, Pseudo-F = 1.3821, p= 0.14).
The OTUs making the greatest contribution to the microbiota
difference between BA and BAL samples were determined using
the SIMPER (PRIMER) analysis (Supplementary Figure S3).
The two most discriminating OTUs (>2% contribution, square-
root transformed data) were OTU139321 from Pseudomonas
and OTU92651 from Staphylococcus. However, the contributions
of these OTUs to BALs–BAs dissimilarity were not consistent
(dissimilarity/SD of 0.68 and 0.56, respectively), which was also
the case with other OTUs.
Microbiota comparisons based on the proportion of genera
also showed clustering by individual (Supplementary Figure S2).
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FIGURE 8 | Longitudinal analysis of the microbiota colonizing the conducting and respiratory zones of two non-CF patients. Bar graphs indicate the
relative abundances of the genera identified by 16S rRNA gene sequencing. Bar graphs are presented by pairs: left, bacterial composition of BAs; right, bacterial
composition of BALs. The number below the bar graphs indicates the time of sampling expressed in day post-LT. Only genera with relative abundance of >1% in at
least one of the samples are presented. OTUs unassigned to a genus are pooled to represent the category “Unknown genera” while low-abundance genera (<1%)
are pooled to represent the category “Genera <1%.”
Again, statistical tests did not find a significant effect of the
sample type (Permanova Pseudo-F = 1.4283, p = 0.1595), CF
pathology (Permanova Pseudo-F = 1.2094, p = 0.2603), or age
(DISTLM Pseudo-F = 1.6647, p = 0.0964) on the microbiota
profiles. Variation in community structure was explained by
inter-individual differences (global Permanova test Pseudo-
F = 4.7571, p = 0.0001), number of antibiotics administered
(DISTLM Pseudo-F = 4.252, p = 0.0002) and the time interval
post-transplantation (DISTLM Pseudo-F = 2.5786, p= 0.0136).
Microbiota of the Conducting and
Respiratory Zones Display Similar
Changes after Transplantation
We investigated changes in the microbiota in five and
six BA–BAL pairs collected longitudinally in two patients
during 6 months and 1 year post-LT, respectively (Figure 8).
Longitudinal analysis of BA–BAL pairs of patients #3 and #12
showed dynamic modifications of the microbiota over time.
However, the microbiota remained highly similar between pairs
of BA and BAL samples. Microbiota of patient #3 was dominated
by Prevotella at day 14, which was replaced by Corynebacterium
at day 84. In contrast, Anaerococcus was over-represented in BA–
BAL pairs of patient #12. The longitudinal microbial colonization
of patients #3 and #12 shows a wave-like profile constituted by
a dominant species at mid-term. However, the analysis of only
two colonization profiles did not allow us to obtain a statistical
significance for the time-dependent changes of the microbiota.
DISCUSSION
In this study, we characterized and compared the microbiota
between the conducting (BA) and respiratory zones (BAL) of
lung-transplant recipients over time. We show that although
bacterial richness was higher in samples from the respiratory
as compared to the conducting zone, population diversity and
structure between these two sites were similar. Furthermore,
we show dynamic changes of the microbiota of both sites over
time.
In healthy patients Dickson et al. (2015a) showed decreasing
community richness with increasing distance from the source
community of the upper respiratory tract. Our finding that,
in average, the bacterial richness is higher in respiratory
than in conducting airways could be a characteristic of lung-
transplant recipients. We could hypothesize that the microbiota
of the conducting zone is more representative of the recipient’s
microbiota, whereas the microbiota of respiratory airways more
reflects the donor microbiota, explaining a higher richness in the
respiratory airway samples. Another hypothesis could be that the
immunosuppression of lung transplant recipients is responsible
for difference between these patients and healthy controls.
Transplanted and non-transplanted patients share a common
background lung microbiota, characterized by bacteria found
also in the oral and upper respiratory tract (Willner et al., 2013;
Becker et al., 2014). Considerable regional variations impacting
on bacterial growth and survival exist in lungs, including oxygen
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tension, temperature, abundance of inflammatory cells, and
gastroesophageal reflux (Dickson et al., 2015b). Strikingly in
previous reports BALs more closely related to the oral microbiota
of the same patient than to BALs of other patients (3). However,
the divergence between BALs and oral microbiota was more
pronounced in transplant patients than in non-transplant control
subjects. Furthermore, oral and proximal lung microbiota of a
young CF child were different from the microbiota of distal lung
sections (Brown et al., 2014). In the present study lung microbiota
post-LT showed a relative spatial homogeneity reflected by
similar microbial populations in the BAs and BALs. Given
the absence of detectable cross-contamination during an ex
vivo performed control experiment, it is unlikely that relevant
cross-contamination between BA and BAL samples explains this
observation.
The intra-patient clustering of BA–BAL pairs from the
same day, together with a tendency to cluster for samples
at different time-points for each patient contrasts with a
lower inter-individual similarity inside a collection zone, and
supports an individual microbial signature following LT. CF
patients are frequently colonized by bacterial pathogens which
can seed the allograft from the nasopharyngeal reservoir
(Leung et al., 2008). However, we did not find a typical
microbiota CF signature compared to non-CF lung transplant
recipients.
We found in both conductive and respiratory zones a large
predominance of Firmicutes and Proteobacteria, as well as an
inverse correlation between these two phyla. Overrepresentation
of Proteobacteria, which includes major lung pathogens, and such
an inverse correlation have been previously linked to the severity
of disease in COPD patients (Garcia-Nunez et al., 2014). Whether
overrepresentation of Proteobacteria in lung transplant recipients
is associated with allograft failure remains to be studied in a larger
cohort.
While the Bray–Curtis similarity between BA and BAL
in pairs of samples did not show any obvious trends in
changes over time, variation in microbiota structure was
linked to the number of antibiotics used and the time
interval after LT. In addition, the antibiotic number and time
post-transplantation influenced the dynamic changes of the
community structure in both zones over time, confirming
previous observations on the impact of antibiotics in CF lung
transplant recipients (Willner et al., 2013). Interestingly whereas
antibiotics impacted on community structure and diversity, this
effect did not endure in non-transplanted CF patients leading
to the conclusion that the microbiota is resilient to antibiotic
exposure (Fodor et al., 2012; Stressmann et al., 2012; Zhao et al.,
2012).
Our study represents the real-life situation with its associated
potential limitations. All our patients were exposed to antibiotics
impacting both structure and changes of the microbiota. Given
the difficulty to obtain clinical samples the number of subjects
analyzed is also relatively low precluding a definite conclusion
about taxa that may discriminate BA and BAL samples, as well
as CF from non-CF recipients.
A relative similarity in microbial profiles in BA and BAL
samples may have important clinical implications. BA samples
are obtained by less invasive methods than BAL samples and
therefore may possibly be used instead of BALs in clinical
microbiological diagnostics. In future work, it will be interesting
to analyze longitudinal samples collected in pairs from the
sinuses, the oral cavity, the main bronchia, and the lower airways.
This should provide information on the dynamics of bacterial
graft colonization, the contribution of the upper airways in this
process and on the microbial movements between the different
airway zones.
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